Interpreting and Reporting Minimal Residual Disease Testing Data for Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing
. , (acute lymphoblastic leukemia, ALL) 10 -4 0.01% (10,000 1 ) ." (measurable residual disease)" . (immunoglobulin, IG) T- (T-cell receptor, TCR)
Authors
- Young‐Uk Cho (ORCID: https://orcid.org/0000-0002-4403-8989)
- Daehyun Chu (ORCID: https://orcid.org/0000-0001-9086-8740)
- Miyoung Kim (ORCID: https://orcid.org/0000-0002-8903-5044)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Laboratory Medicine Online
- Published
- 2024-09-26
- DOI
- https://doi.org/10.47429/lmo.2024.14.4.287
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00